WELCOME TO The HEALTHCARE REPORT
Newsletter | Member Login | Signup
Home > Companies > Integra Health
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Conference
Webinar
HEALTH TECHNOLOGY
HealthVerity | November 17, 2020
HealthVerity, the pioneer in security ensured data exchange, today reported the business accessibility of its incorporated cloud stage offering adaptable advancements that enable medical care endeavors to plan and assemble their own one of a kind data technique, data work process or data universe, all in a security ensured way. Upheld by an amazing API (application programming interface) suite, HealthVerity customers ca...
FUTURE OF HEALTHCARE
Revelstoke | February 25, 2022
Revelstoke Capital Partners ("Revelstoke"), aDenver-based private equity firm focused on investing in healthcare services companies, today announced it has made a significant growth investment in ClareMedica Health Partners, LLC ("ClareMedica" or the "Company"), a leader in value-based primary care serving Medicare Advantage members inFlorida. This partnership will accelerate ClareMedica's growth and aid the Company in expanding itsBette...
Antengene Corporation Limited | September 19, 2022
Antengene Corporation Limited a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hematology and oncology, announced that ATG-101, the company's in-house developed novel PD-L1/4-1BB bispecific antibody, has been granted an Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic cancer. This ODD will help Antenge...
Healthcare IT News | March 23, 2020
Amazon joins a growing list of global technology giants stepping up to help battle the global COVID-19 pandemic through the AWS Diagnostic Development Initiative, which aims to accelerate COVID-19 diagnostics, research, and testing. The program, which is backed by an initial investment of $20 million, is open to accredited research institutions and private entities using AWS to support research-oriented workloads for the development of point-of-care diagnostics. This type of diagnostic treatment...
Article
infographic
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE